Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 6/20 | 0.47 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.36 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2555697 | 0.80 | FDPS (0.42) | FDPSFNTAFNTBPLA2G2CPLA2G2A | |
| SCHEMBL2552685 | 0.80 | FDPS (0.42) | FDPSFNTAFNTBPLA2G2CPLA2G2A | |
| SCHEMBL4856257 | 0.79 | PLA2G2C (0.56) | PLA2G2CCA2MAPK1 | |
| SCHEMBL20914941 | 0.79 | PLA2G2C (0.51) | PLA2G2CCA2MAPK1TAS1R3TAS1R1 | |
| SCHEMBL1388452 | 0.79 | CA2 (0.48) | PLA2G2CCA2MAPK1TAS1R3TAS1R1 | |
| SCHEMBL4820679 | 0.77 | PLA2G2C (0.46) | PLA2G2CCA2MAPK1CA1 | |
| SCHEMBL16762206 | 0.77 | PLA2G2C (0.46) | PLA2G2CCA2MAPK1CA1 | |
| SCHEMBL5953705 | 0.77 | PLA2G2C (0.59) | PLA2G2CCA2 | |
| SCHEMBL4820666 | 0.77 | PLA2G2C (0.46) | PLA2G2CCA2MAPK1CA1 | |
| SCHEMBL4856599 | 0.77 | PLA2G2C (0.59) | PLA2G2CCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020058834-A1 | Preparation of N-acyl amino carboxylic acids, amino carboxylic acids and their derivatives by metal-catalyzed carboxymethylation in the presence of a promoter | MONSANTO TECHNOLOGY LLC | 2002-05-16 | — | — | US | claimed |
| WO-2001092208-A1 | METAL-CATALYSED CARBOXYMETHYLATION IN THE PRESENCE OF A PROMOTER | MONSANTO TECHNOLOGY LLC (US) | 2001-12-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058834-A1 | Preparation of N-acyl amino carboxylic acids, amino carboxylic acids and their derivatives by metal-catalyzed carboxymethylation in the presence of a promoter | BCAT2, GNMT, BCAT1 | FDPS 2983/4885FNTA 402/4885FNTB 1396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.